Lobby Letter to CFDA on Labelling Requirement for Infant Formula Registration

2017-06-22 | Beijing

The Paediatric Nutrition Desk submitted a lobby letter to the CFDA on revising labelling requirements for the registration review of the infant formula. The CFDA held a seminar in Harbin to give official interpretation for the labelling guidelines. However, some problems remain unclear. The Desk therefore collected the common industry concerns, such as the "Organic" mark, labelling of the patent number, etc, and consolidated industry comments to a lobby letter for the CFDA's further clarification thereof.